Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$1.7 million.

  • Envoy Medical's Net Cash Flow fell 16457.63% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$870000.0, marking a year-over-year increase of 9299.01%. This contributed to the annual value of $1.3 million for FY2024, which is 6857.36% down from last year.
  • As of Q3 2025, Envoy Medical's Net Cash Flow stood at -$1.7 million, which was down 16457.63% from -$23000.0 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Net Cash Flow ranged from a high of $16.8 million in Q3 2023 and a low of -$12.6 million during Q4 2023
  • For the 4-year period, Envoy Medical's Net Cash Flow averaged around $174866.7, with its median value being -$23000.0 (2025).
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Net Cash Flow was 418970.98% (2023), while the steepest drop was 290476.19% (2023).
  • Quarter analysis of 4 years shows Envoy Medical's Net Cash Flow stood at -$420000.0 in 2022, then plummeted by 2904.76% to -$12.6 million in 2023, then soared by 108.4% to $1.1 million in 2024, then tumbled by 263.21% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q3 2025, -$23000.0 for Q2 2025, and -$177000.0 during Q1 2025.